Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

Stephanie Green, Geoffrey R. Weiss · Investigational New Drugs · 1992 · 616 citations

Medicine, Oncology, Medical Oncology +14

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study

Roger K.C. Ngan, Harry Yiu, W.H. Lau et al. · Annals of Oncology · 2002 · 176 citations · Full text

Medicine, Oncology, Pharmacology +15

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

Kian Fong Foo, E.H. Tan, Swan Swan Leong et al. · Annals of Oncology · 2002 · 128 citations

Medicine, Cancer Biology, Oncology +8

Chemotherapy with gemcitabine‐containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma

Ian F. Tannock, Gregory R. Pond, Matthew R. Edmonds et al. · Cancer · 2002 · 81 citations

Medicine, Oncology, Pharmacotherapy +14

Recent advances in the treatment of nasopharyngeal carcinoma.

Joseph Tung‐Chieh Chang, Jenq‐Yuh Ko, Ruey‐Long Hong · PubMed · 2004 · 32 citations

Medicine, Oncology, Radiation Oncology +14